These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 27846818)

  • 21. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation.
    Lanzas C; Dubberke ER
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):1043-50. PubMed ID: 25026622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of toxigenic
    Vaughn JL; Balada-Llasat JM; Lamprecht M; Huang Y; Anghelina M; El Boghdadly Z; Bishop-Hill K; Childs R; Pancholi P; Andritsos LA
    J Med Microbiol; 2018 Jul; 67(7):976-981. PubMed ID: 29863458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorrect diagnosis of Clostridium difficile infection in a university hospital in Japan.
    Mori N; Yoshizawa S; Saga T; Ishii Y; Murakami H; Iwata M; Collins DA; Riley TV; Tateda K
    J Infect Chemother; 2015 Oct; 21(10):718-22. PubMed ID: 26238001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications.
    Furuya-Kanamori L; Marquess J; Yakob L; Riley TV; Paterson DL; Foster NF; Huber CA; Clements AC
    BMC Infect Dis; 2015 Nov; 15():516. PubMed ID: 26573915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
    Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
    Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya.
    Oyaro MO; Plants-Paris K; Bishoff D; Malonza P; Gontier CS; DuPont HL; Darkoh C
    Int J Infect Dis; 2018 Sep; 74():24-28. PubMed ID: 29960098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the epidemiology and microbiology of Clostridium difficile carriage in elderly patients and residents of a healthcare facility in southern Ontario, Canada.
    Mallia G; Van Toen J; Rousseau J; Jacob L; Boerlin P; Greer A; Metcalf D; Weese JS
    J Hosp Infect; 2018 Aug; 99(4):461-468. PubMed ID: 29408207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
    Gómez S; Chaves F; Orellana MA
    Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frequency of asymptomatic carriage of toxigenic Clostridium difficile in an acute care geriatric hospital: prospective cohort study in Switzerland.
    Pires D; Prendki V; Renzi G; Fankhauser C; Sauvan V; Huttner B; Schrenzel J; Harbarth S
    Antimicrob Resist Infect Control; 2016; 5():24. PubMed ID: 27280019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile stool shedding in infants hospitalized in two neonatal intensive care units is lower than previous point prevalence estimates using molecular diagnostic methods.
    Hines AG; Freifeld A; Zhao X; Berry AA; Willett L; Iwen PC; Simonsen KA
    BMC Pediatr; 2018 Apr; 18(1):137. PubMed ID: 29653526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of Clostridium difficile colonization.
    Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Jun; 48(3):241-8. PubMed ID: 24890755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
    Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
    Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Missed diagnosis of Clostridium difficile infection; a prospective evaluation of unselected stool samples.
    Reigadas E; Alcalá L; Marín M; Burillo A; Muñoz P; Bouza E
    J Infect; 2015 Mar; 70(3):264-72. PubMed ID: 25452039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.
    Stoesser N; Eyre DW; Quan TP; Godwin H; Pill G; Mbuvi E; Vaughan A; Griffiths D; Martin J; Fawley W; Dingle KE; Oakley S; Wanelik K; Finney JM; Kachrimanidou M; Moore CE; Gorbach S; Riley TV; Crook DW; Peto TEA; Wilcox MH; Walker AS;
    PLoS One; 2017; 12(8):e0182307. PubMed ID: 28813461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.